Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

Cancer Chemotherapy and Pharmacology

Volumn 61, Issue 1, 2008, Pages 47-52

  Lee, Jeeyun ^a   Kim, Tae You ^b   Lee, Myung Ah ^c   Ahn, Myung Ju ^a,d,j   Kim, Hoon Kyo ^e   Lim, Ho Yeong ^a,f,j   Lee, Nam Su ^g   Park, Byung Joo ^h   Kim, Jun Suk ⁱ  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f Ajou University Medical Center   (South Korea)

^g Soonchunhyang University   (South Korea)

^h Seoul National University   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Samsung Medical Center   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; GALLBLADDER CARCINOMA; HUMAN; MALE; METASTASIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CISPLATIN; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; VOMITING;

EID: 34848831495     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0444-5     Document Type: Article

References (22)

1. Shin HR, Jung JK, Won YJ, Park JG (2004) 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat 36:103-114
2. Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2:10
3. Oertli D, Herzog U, Tondelli P (1993) Primary carcinoma of the gallbladder: operative experience during a 16 year period. Eur J Surg 159(8):415-420
4. Alexander F, Rossi RL, O'Bryan M, Khettry U, Braasch JW, Watkins E Jr (1984) Biliary carcinoma. A review of 109 cases. Am J Surg 147(4):503-509
5. Wade TP, Prasad CN, Virgo KS, Johnson FE (1997) Experience with distal bile duct cancers in US. Veterans Affairs hospitals: 1987-1991. J Surg Oncol 64(3):242-245
6. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341(18):1368-1378
7. Scheithauer W (2002) Review of gemcitabine in biliary tract carcinoma. Semin Oncol 29(6 Suppl 20):40-45
8. Arroyo G, Gallardo J, Rubio B, et al (2001) Gemcitabine (GEM) in advanced biliary tract cancer (ABTC). Experimence from Chile and Argentina in phase II trials. Proc Am Soc Clin Oncol 20:A626
9. Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N, et al (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19(20):4089-4091
10. Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, et al (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12(2):183-186
11. Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ (1996) Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2(3):521-530
12. Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ (1995) Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22(4 Suppl 11):72-79
13. Carraro S, Servienio P, Bruno MF, Castillo Odena MDS, Roca E, Jovtis S, Felci N, Araujo C (2001) Gemcitabine and cisplatin in locally advanced or metastatic gallbladder and bile duct adenocarcinomas. Proc Am Soc Clin Oncol 20:A2333
14. Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, et al (2004) A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 90(8):1516-1520
15. Lee GW, Kang JH, Kim HG, Lee JS, Lee JS, Jang JS (2006) Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol 29(2):127-131
16. Thongprasert S, Napapan S, Charoentum C, Moonprakan S (2005) Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16(2):279-281
17. Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH, et al (2006) A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106(6):1339-1346
18. Reyes-Vidal J GJ, Cerda B et al (2003) Gemcitabine and cisplatin in the treatment of patients with unresectable or metastatic gallbladder cancer: results of the phase II GOCCHI study 2000-13. Proc Am Soc Clin Oncol 22:273:1095 (Abstract)
19. Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA (2005) Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer 93(2):195-199
20. Cho JY, Nam JS, Park MS, Yu JS, Paik YH, Lee SJ, et al (2005) A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma. Yonsei Med J 46(4):526-531
21. Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, et al (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23(10):2332-2338
22. Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15(9):1339-1343